Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...